STOCK TITAN

Structure Therapeutics Announces Participation in Upcoming Investor Conferences

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
conferences

Structure Therapeutics (NASDAQ: GPCR) will participate in two June 2026 healthcare investor conferences, featuring fireside chats and 1x1 meetings.

Events include the Jefferies Global Healthcare Conference on June 3 in New York and the Goldman Sachs 47th Annual Global Healthcare Conference on June 9 in Miami, with live and archived webcasts available for 90 days.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • None.

Negative

  • None.

SAN FRANCISCO, May 26, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced that management will participate in two upcoming healthcare conferences in June:

2026 Jefferies Global Healthcare Conference
 Format:Fireside chat and 1x1 meetings
 Date/time:Wednesday, June 3 at 12:15 p.m. ET
 Location:New York, NY
   
Goldman Sachs 47th Annual Global Healthcare Conference
 Format:Fireside chat and 1x1 meetings
 Date/time:Tuesday, June 9 at 10:00 a.m. ET
 Location:Miami, FL


The live and archived webcasts will be accessible from the company’s website at https://ir.structuretx.com/events-presentations/events and replays will be available for 90 days.

About Structure Therapeutics
Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, the Company has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage oral small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more people living with obesity around the world. For additional information, please visit www.structuretx.com.

Investors:
Corey Davis, Ph.D.
LifeSci Advisors, LLC
212-915-2577
cdavis@lifesciadvisors.com

Jun Yoon
Structure Therapeutics Inc.
ir@structuretx.com

Media:
Dan Budwick
1AB
Dan@1abmedia.com


FAQ

When will Structure Therapeutics (NASDAQ: GPCR) present at the 2026 Jefferies Global Healthcare Conference?

Structure Therapeutics will present at the 2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026, at 12:15 p.m. ET. According to the company, the event in New York will feature a fireside chat and 1x1 investor meetings.

What are the details of Structure Therapeutics' appearance at the Goldman Sachs 47th Annual Global Healthcare Conference?

Structure Therapeutics will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9, 2026, at 10:00 a.m. ET. According to the company, the Miami event will include a fireside chat and 1x1 meetings with investors.

How can investors access the Structure Therapeutics (GPCR) webcasts for the June 2026 conferences?

Investors can access live and archived webcasts of both June 2026 conferences through Structure Therapeutics’ investor relations website. According to the company, replays of the events will remain available online for 90 days after the presentations.

Where will Structure Therapeutics hold its June 2026 investor conference fireside chats?

Structure Therapeutics will hold its June 2026 fireside chats in New York, NY, at the Jefferies Global Healthcare Conference and in Miami, FL, at the Goldman Sachs 47th Annual Global Healthcare Conference. Both appearances also offer online webcasts and replays.

What format will Structure Therapeutics use for its presentations at the June 2026 healthcare conferences?

Structure Therapeutics will use a fireside chat format combined with 1x1 investor meetings at both June 2026 healthcare conferences. According to the company, this structure aims to provide more detailed discussions with investors alongside the main public session.